SynBioBeta Speaker
Dong-Eun Chang
GFfermentech
Vice President
At HLB Genex & GF Fermentech, we specialize in advancing synthetic biology innovations from laboratory-stage concepts to scalable industrial production. Our work centers on enzyme engineering, strain optimization, and precision fermentation, supported by a 160 kL manufacturing infrastructure. Through an integrated CDMO platform, we help partners streamline the transition from R&D to commercial manufacturing, with strengths in advanced downstream processing, high-purity production, and LMO-certified operations. Our focus is on enabling the efficient and reliable market entry of complex enzymes and functional biomaterials.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Dong-Eun
This Year
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
